Catherine Sarkisian on Muck Rack

Catherine Sarkisian

Los Angeles
As seen in: USA Today, Wiley Online Library, PLOS ONE, JAMA (The Journal of the American Medical Association), JAMA Internal Medicine Author Interviews, JAMA Network, The New England Journal of Medicine, STAT, NorthJersey.com, The Indianapolis Star and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Catherine

Contact Catherine, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

An Electronic Health Record “Nudge” to Reduce Antipsychotic Medication Prescribing for Primary Care Patients With Dementia: A Pragmatic RCT

|
By Julie Bynum MD, Catherine Sarkisian, Chad Wes Villaflores
| Wiley Online Library Verified
1 Introduction Antipsychotic medications occupy a limited and carefully circumscribed role in the management of behavioral and psychological symptoms of dementia (BPSD). Current guidelines recommend non-pharmacologic interventions as first-line treatment, with antipsychotics reserved for patients with severe agitation, aggression, or psychosis that pose a risk of harm or cause substantial distress and have not responded to behavioral approaches [1, 2].
Open in Who Shared Issue with article?

State Cost Growth Benchmark Programs and Total Medical Expenditures, 2010 to 2020

|
By Aleena Imran, Carlos Irwin Oronce, Nicholas Jackson, Ya-Chen Tina Shih, Cheryl L. Damberg, Catherine Sarkisian, John N. Mafi
| JAMA Network Verified
Supplement 1. eMethods. Supplementary Methods Supplement 2. Figure. Line Graphs of Preimplementation and Postimplementation Trends in Per Capita Health Care Spending Growth for Treatment and Control States (opens in new tab) These figures plot average log per capita health care spending in Massachusetts, Maryland, Vermont, Delaware, and Rhode Island compared with matched control states. The vertical light blue line indicates the year the state implemented its cost-growth benchmark program.
Open in Who Shared Issue with article?

Reducing Wasteful Spending on Discarded Lecanemab

|
By Frank Zhou, Cheryl L. Damberg, Catherine Sarkisian
| JAMA Internal Medicine Author Interviews
Lecanemab, an infusion drug for Alzheimer disease, could cost Medicare billions of dollars annually.1 Because lecanemab dosing is weight-based (10 mg/kg every 2 weeks) and only available in single-use 500- and 200-mg vials,1 substantial leftover drug may lead to wasteful spending.2 In a cross-sectional study, we quantified the projected cost of discarded lecanemab in the US Medicare program and modeled potential savings from using alternative vial sizes.
Open in Who Shared Issue with article?
See all 12 licensed articles (15 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified